Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

1st Quarter Results

12 Sep 2024 07:00

RNS Number : 8053D
British Smaller Companies VCT PLC
12 September 2024
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 30 June 2024

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 30 June 2024. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

As previously announced on 20 August 2024, in the quarter to 30 June 2024 the Company's Net Asset Value per share was down by 0.1 pence to 83.5 pence, with promising progress and strong growth rates of a number of portfolio companies moderated by company-specific circumstances in other businesses in the portfolio. The FTSE Small Cap Index rose by 5.3 per cent during the period.

The Company's Total Return at 30 June 2024 was down 0.1 pence, to 262.4 pence per ordinary share.

During the quarter, the Company invested £6.8 million into three new investments: Fuuse, Ohalo and Spotless Water; and invested a further £2.3 million into existing portfolio companies Plandek and Summize. Subsequent to the quarter end, the Company has invested £8.8 million into four existing portfolio companies: AutomatePro, SharpCloud, Quality Clouds and Xapien, taking the total amount invested so far this year to £17.9 million.

The Company, alongside British Smaller Companies VCT2 plc, raised £90 million in aggregate under the offers launched on 20 September 2023 in relation to the 2023/24 tax year. A total of £55.4 million was raised by the Company, of which £18.6 million had been allotted on 30 January 2024 and £36.8 million was allotted on 3 April 2024.

Performance

The table below sets out movements in key metrics for the Company. 

 

 

31 March 2024

Decrease in Value

Shares issued

Buyback of shares

Movement

In Period

30 June 2024

Net Assets (£m)

219.6

(0.4)

35.7

(2.4)

32.9

252.5

NAV per share (PPS)

83.6

(0.1)

-

-

(0.1)

83.5

Cumulative dividends paid (PPS)

178.9

-

-

-

-

178.9

Total Return (PPS)

262.5

(0.1)

-

-

(0.1)

262.4

Shares in issue

262,659,361

-

42,588,037

(2,972,034)

39,616,003

302,275,364

Cumulative dividends paid at 30 June 2024 were 178.9 pence per ordinary share (31 March 2024: 178.9 pence per ordinary share).

The movements in NAV and NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 March 2024

219.6

83.6

Decrease in portfolio value

(0.9)

(0.3)

Net operating income

0.5

0.2

(0.4)

(0.1)

Issue/buy-back of shares

33.3

-

Total Return in the period

32.9

(0.1)

NAV at 30 June 2024

 

252.5

 

83.5

 

Dividends and shares in issue

On 3 April 2024 the Company issued 42,588,037 shares in relation to the second and final allotment from its 2023/24 fundraising.

Under its standing buyback authority, on 24 June 2024 the Company purchased 2,972,034 shares at 79.92 pence per share at a cost of £2.4 million. These shares are held in treasury. 

Post-period end, on 26 July 2024, a dividend of 2.0 pence per ordinary share for the year ending 31 March 2025 was paid, resulting in a corresponding reduction in the Company's NAV per ordinary share, adjusting the last reported NAV to 81.5 pence per ordinary share. Cumulative dividends paid are now 180.9 pence per ordinary share.

On 26 July 2024 the Company issued 1,369,910 shares under the Company's Dividend Re-investment Scheme (DRIS). following which the Company's issued share capital consists of 303,645,274 ordinary shares with voting rights and 28,610,455 shares held in treasury.

Net assets

Net assets at 30 June 2024 comprised the following:

£000

% of net assets

Unquoted investments at fair value

134,734

53.4

Cash and money market funds

114,097

45.2

Other net assets

3,664

1.4

Net assets

252,495

100.0

Investments

The investment portfolio at 30 June 2024 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

24,076

9.5%

Unbiased

13,889

15.0%

Outpost

8,506

18.4%

Elucidat

6,106

20.8%

Vypr

5,947

23.2%

Force24

5,781

25.5%

SharpCloud

5,565

27.7%

ACC Aviation

5,299

29.8%

Plandek

4,043

31.4%

Quality Clouds

3,930

32.9%

83,142

32.9%

Other investments

51,592

53.4%

Total investments

134,734

53.4%

Portfolio performance

Over the quarter to 30 June 2024, the aggregate unquoted portfolio valuation has decreased by £0.9 million.

Fundraising

On 20 August 2024, the Company announced its intention to launch a new joint offer for subscription for the tax year 2024/25 later this year, alongside British Smaller Companies VCT2 plc (together the "Companies"). As announced on 10 September 2024, the current intention is for the Companies, in aggregate, to raise up to £50 million, with over-allotment facilities of up to a further £25 million in aggregate, before issue costs. Any election to make use of their over-allotment facility will be subject to the decision of the individual boards of the Companies at the relevant time.

 

A prospectus with full details of the proposed Offer is expected to be published in mid-October, with applications expected to open one week following publication. Once published, the prospectus will be available from the Companies' website, www.bscfunds.com.

Outlook

The UK economy is showing encouraging signs, with interest rates beginning to come down from their recent highs after the CPI inflation rate reached the Bank of England's 2.0 per cent target. There is also the promise of greater political stability following July's general election and a government agenda focused on growth.

However, global uncertainty remains, with some market turbulence driven by concerns over the US economy, as well as the outcome of the US election in November.

In this environment, the Company is focused on accelerating the growth of its most promising and fastest-growing assets, while also supporting companies currently facing challenges.

There is an encouraging pipeline of new opportunities, and it is expected that the portfolio will see further additions in the coming months.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

12 September 2024

For further information please contact:

Marcus Karia YFM Equity Partners Tel: 0113 244 1000

Alex Collins Panmure Liberum Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFEAFNFFFXLEFA
Date   Source Headline
11th Jun 202612:15 pmRNSAnnual Financial Report
20th Apr 202610:00 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:10 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNS3rd Quarter Results
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSHalf-year Financial Report
20th Nov 20259:00 amRNSOffer Update
11th Nov 20257:00 amRNSDividend Declaration
27th Oct 202511:00 amRNSNominal Capital Reduction
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSInterim Management Statement
9th Sep 202512:56 pmRNSResult of AGM
22nd Aug 202510:45 amRNSNew combined offer for subscription
25th Jul 202510:16 amRNSPayment of dividend and issue of Equity
24th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20251:30 pmRNSAnnual Financial Report
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:13 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNS3rd Quarter Results
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:23 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
20th Dec 20249:26 amRNSPayment of dividend and issue of equity
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:09 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNSHalf-year Report
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
14th Nov 20247:48 amRNSDividend Declaration
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.